{
     "PMID": "15653257",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20050609",
     "LR": "20161124",
     "IS": "0920-9964 (Print) 0920-9964 (Linking)",
     "VI": "73",
     "IP": "2-3",
     "DP": "2005 Mar 1",
     "TI": "Chronic phencyclidine administration induces schizophrenia-like changes in N-acetylaspartate and N-acetylaspartylglutamate in rat brain.",
     "PG": "147-52",
     "AB": "Administration of phencyclidine (PCP) to both humans and animals models the symptoms of schizophrenia. Brain concentrations of N-acetylaspartate (NAA) are reduced in this disease, reflecting neuronal dysfunction. This study investigates the effects in rats of a chronic intermittent regime of PCP on NAA and its precursor N-acetylaspartylglutamate (NAAG) in rat frontal and temporal cortex, hippocampus and striatum, determined by HPLC. We found significant PCP-induced deficits of NAA and NAAG only in the temporal cortex; NAAG was significantly elevated in the hippocampus. These changes closely reflect postmortem findings reported in schizophrenia.",
     "FAU": [
          "Reynolds, Lindsay M",
          "Cochran, Susan M",
          "Morris, Brian J",
          "Pratt, Judith A",
          "Reynolds, Gavin P"
     ],
     "AU": [
          "Reynolds LM",
          "Cochran SM",
          "Morris BJ",
          "Pratt JA",
          "Reynolds GP"
     ],
     "AD": "Department of Biomedical Science, University of Sheffield, Western Bank, Sheffield S10 2TN, UK. l.m.reynolds@shef.ac.uk",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "PL": "Netherlands",
     "TA": "Schizophr Res",
     "JT": "Schizophrenia research",
     "JID": "8804207",
     "RN": [
          "0 (Dipeptides)",
          "0 (Hallucinogens)",
          "1W8M12WXYL (isospaglumic acid)",
          "30KYC7MIAI (Aspartic Acid)",
          "997-55-7 (N-acetylaspartate)",
          "J1DOI7UV76 (Phencyclidine)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Aspartic Acid/*analogs & derivatives/*metabolism",
          "Brain/*drug effects/physiopathology",
          "Chromatography, High Pressure Liquid",
          "Corpus Striatum/drug effects",
          "Dipeptides/*metabolism",
          "Disease Models, Animal",
          "Dose-Response Relationship, Drug",
          "Frontal Lobe/drug effects",
          "Hallucinogens/*adverse effects",
          "Hippocampus/drug effects",
          "Male",
          "Phencyclidine/*adverse effects",
          "Psychotic Disorders/*etiology/physiopathology",
          "Rats",
          "Rats, Long-Evans",
          "Temporal Lobe/drug effects"
     ],
     "EDAT": "2005/01/18 09:00",
     "MHDA": "2005/06/10 09:00",
     "CRDT": [
          "2005/01/18 09:00"
     ],
     "PHST": [
          "2004/02/04 00:00 [received]",
          "2004/02/04 00:00 [revised]",
          "2004/02/04 00:00 [accepted]",
          "2005/01/18 09:00 [pubmed]",
          "2005/06/10 09:00 [medline]",
          "2005/01/18 09:00 [entrez]"
     ],
     "AID": [
          "S0920996404000519 [pii]",
          "10.1016/j.schres.2004.02.003 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Schizophr Res. 2005 Mar 1;73(2-3):147-52. doi: 10.1016/j.schres.2004.02.003.",
     "term": "hippocampus"
}